Navigation Links
ESA's Corona(R) Family of HPLC Detectors, Including the New Corona ultra(TM), Can Now be Controlled by Waters Empower(R) 2 Chromatography Software
Date:5/11/2009

New control option maximizes UHPLC or HPLC productivity via seamless hardware/software interface; Driver available free of charge to all new and existing Corona detector customers

CHELMSFORD, Mass., May 11 /PRNewswire/ -- Integrating a Corona ultra UHPLC detector with a Waters ACQUITY UPLC(R) or Alliance(R) HPLC system is easy thanks to a new Empower 2/Corona detector instrument-control software driver. ESA Biosciences, Inc., a Magellan Biosciences company and leader in novel HPLC systems that improve results for pharmaceutical development and QA/QC, life science, and analytical-chemistry customers worldwide, announced that the driver for Waters' chromatography control and data-analysis platform is available free of charge to new and existing customers. The software driver comes standard with all new Corona detectors. The driver can also be used with ESA's Corona CAD(R) and Corona Plus detectors. Existing customers can download a copy by visiting: http://www.esainc.com/services/software_downloads/empower_driver.

"The development of this driver had its genesis in customer labs, since so many have standardized on both the ESA Corona and Waters platforms. Customers asked for it, and we were pleased to work with Waters to deliver," said Jasmine Gruia-Gray, PhD, president of ESA's life science tools business. "Our product-development goal with the Corona ultra was to make it work seamlessly with the leading U/HPLC brands to help customers streamline their processes, improve productivity, and take full advantage of the power and capabilities inherent in these high-performance systems. The detector is rugged and designed to fit with the other U/HPLC components anywhere within the stack -- no additional bench space is necessary. Now, with the Empower 2 - Corona detector instrument control software, customers can also have single-point system management and control."

Besides excellent sensitivity, the Corona ultra shows consistent inter-analyte response independent of chemical structure. This breakthrough instrument can effectively detect a wide diversity of chemical structures and important classes of molecules -- from small organic molecules, proteins and peptides, to ions, carbohydrates, lipids, and polymers. The Corona ultra makes methods development, validation, and transfer fast and easy for a wide range of life-science research applications and industries: pharmaceutical, chemical, polymer, food and beverage, biofuel, oils, petrochemical, and more. Suited for analytical R&D scientists looking for improved throughput and resolution as well as for those in manufacturing QC requiring real-time quality control, Corona ultra ensures you see the complete analytical picture. For more information, visit www.corona-ultra.com.

About ESA Life Science Tools (www.esainc.com)

A Magellan Biosciences business, ESA Life Science Tools enables answers to pressing analytical challenges for analytical and diagnostics laboratories worldwide. Leaders in HPLC detection, ESA's flexible, applications-focused systems combine specialty detectors with optimized components and consumables -- all designed to achieve maximum performance. ESA's Customer Care experts deliver the highest standard of service to ensure customer confidence, security, knowledge, and support.


'/>"/>
SOURCE ESA Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
2. National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
3. ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080
4. Immune Deficiency Foundation Honors Cerda Family and Volunteers From ABCs Extreme Makeover: Home Edition
5. AmLactin(R) Family of Moisturizers Has a New Look
6. Almost Family to Present at Two Upcoming Conferences
7. Dr. Dan Tobin, Family Caregiving Expert, Featured on Caring.com
8. Almost Family Reports First Quarter 2009 Results
9. ABCs Extreme Makeover: Home Edition Helps Family Coping with Primary Immunodeficiency Disease
10. Almost Family, Inc. to Report First Quarter 2009 Financial Results
11. Survey finds nearly half of Americans concerned they or their family may get sick from swine flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: